Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2024 年第 4 季持倉
持倉截至 2024/12/31，2025/2/14 申報。只含多頭部位，變化是跟 2024 年第 3 季比股數。
- 持股檔數
- 61
- 較 2024 年第 3 季 −8
- 總值
- $26.7 億
- 較 2024 年第 3 季 −$4.65 億 (−14.8%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| DVAXDynavax Technologies Corp | COM NEW | 17,791,486 | $2.27 億 | 8.5% | +5,265,000+42.0% | 加碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 6,419,566 | $1.96 億 | 7.4% | +419,006+7.0% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,000,000 | $1.67 億 | 6.3% | +399,307+24.9% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 6,000,000 | $1.49 億 | 5.6% | +1,652,536+38.0% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 4,274,921 | $1.36 億 | 5.1% | −125,733−2.9% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,460,756 | $1.25 億 | 4.7% | −383,144−10.0% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 2,500,000 | $1.18 億 | 4.4% | +1,870,094+296.9% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 12,836,282 | $1.10 億 | 4.1% | +114,822+0.9% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 4,522,741 | $8,670 萬 | 3.3% | +771,796+20.6% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,972,257 | $7,865 萬 | 2.9% | 00.0% | 不變 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 2,800,000 | $7,594 萬 | 2.8% | +1,579,492+129.4% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,933,928 | $6,761 萬 | 2.5% | −266,072−12.1% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 3,000,000 | $5,652 萬 | 2.1% | −868,104−22.4% | 減碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 3,018,935 | $5,564 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 6,478,249 | $5,066 萬 | 1.9% | +3,711,737+134.2% | 加碼 | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,450,000 | $4,989 萬 | 1.9% | +1,450,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $4,712 萬 | 1.8% | −1,282,000−39.1% | 減碼 | 歷史 |
| SEPNSepterna, Inc. | COM | 1,912,929 | $4,381 萬 | 1.6% | +1,912,929 | 新進 | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 4,000,000 | $4,240 萬 | 1.6% | +3,432,572+604.9% | 加碼 | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 2,000,000 | $4,174 萬 | 1.6% | +2,000,000 | 新進 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 1,490,000 | $4,145 萬 | 1.6% | +800,216+116.0% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 850,000 | $3,947 萬 | 1.5% | −2,330,025−73.3% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,540,132 | $3,892 萬 | 1.5% | +1,540,132 | 新進 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 1,000,000 | $3,860 萬 | 1.4% | +1,000,000 | 新進 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 649,042 | $3,588 萬 | 1.3% | +144,214+28.6% | 加碼 | 歷史 |
| BCAXBicara Therapeutics Inc. | COM | 2,000,000 | $3,484 萬 | 1.3% | +1,203,148+151.0% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 14,218,903 | $3,341 萬 | 1.3% | −1,053,269−6.9% | 減碼 | 歷史 |
| KRROKorro Bio, Inc. | COM | 874,614 | $3,330 萬 | 1.2% | +24,614+2.9% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 5,576,558 | $3,089 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 4,557,575 | $3,031 萬 | 1.1% | +1,949,942+74.8% | 加碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 653,513 | $2,749 萬 | 1.0% | +653,513 | 新進 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 3,579,209 | $2,620 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,350,000 | $2,261 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 819,162 | $2,248 萬 | 0.8% | +819,162 | 新進 | 歷史 |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 780,778 | $2,147 萬 | 0.8% | +780,778 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,442,833 | $2,007 萬 | 0.8% | −557,167−13.9% | 減碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 2,816,594 | $1,960 萬 | 0.7% | −4,248,505−60.1% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 710,421 | $1,897 萬 | 0.7% | −390,115−35.4% | 減碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,276,081 | $1,787 萬 | 0.7% | −2,271,920−64.0% | 減碼 | 歷史 |
| UPBUpstream Bio, Inc. | COM | 1,000,000 | $1,644 萬 | 0.6% | +1,000,000 | 新進 | 歷史 |
| NVAXNovavax Inc | COM NEW | 2,000,000 | $1,608 萬 | 0.6% | +2,000,000 | 新進 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 519,376 | $1,532 萬 | 0.6% | +519,376 | 新進 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 750,000 | $1,454 萬 | 0.5% | −485,187−39.3% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 4,011,287 | $1,420 萬 | 0.5% | −3,563,762−47.0% | 減碼 | 歷史 |
| HELPCybin Inc. | COM NEW | 1,529,987 | $1,349 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| XNCRXencor Inc | COM | 500,000 | $1,149 萬 | 0.4% | −300,000−37.5% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM NEW | 244,110 | $972.5 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 6,011,380 | $949.8 萬 | 0.4% | +6,011,380 | 新進 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,283,783 | $820.9 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $779.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ALLKAllakos Inc. | COM | 5,704,282 | $690.2 萬 | 0.3% | +704,282+14.1% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 169,132 | $663.0 萬 | 0.2% | +169,132 | 新進 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 867,000 | $644.2 萬 | 0.2% | −100,000−10.3% | 減碼 | 歷史 |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 3,119,162 | $570.8 萬 | 0.2% | +1,314,796+72.9% | 加碼 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $515.5 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 219,015 | $509.9 萬 | 0.2% | −780,985−78.1% | 減碼 | 歷史 |
| IVVDInvivyd, Inc. | COM | 10,689,603 | $473.7 萬 | 0.2% | −264,334−2.4% | 減碼 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 523,989 | $450.6 萬 | 0.2% | +523,989 | 新進 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 609,900 | $339.7 萬 | 0.1% | −3,486,552−85.1% | 減碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 1,040,115 | $187.2 萬 | 0.1% | −1,129,028−52.0% | 減碼 | 歷史 |
| NKTRNektar Therapeutics | COM | 1,975,998 | $183.8 萬 | 0.1% | −13,946,657−87.6% | 減碼 | 歷史 |
選擇權（2 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 3 季之後清倉（22 檔）
2024 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 3 季股數 | 2024 年第 3 季市值 | 2024 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ARGXArgenx SE | SPONSORED ADR | 365,000 | $1.98 億 | 6.3% | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 4,950,000 | $1.02 億 | 3.2% | 歷史 |
| ALKSAlkermes plc. | SHS | 3,500,000 | $9,797 萬 | 3.1% | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 857,219 | $7,704 萬 | 2.5% | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,000,000 | $5,874 萬 | 1.9% | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 1,725,000 | $4,035 萬 | 1.3% | 歷史 |
| KURAKura Oncology, Inc. | COM | 1,963,505 | $3,837 萬 | 1.2% | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 600,326 | $2,841 萬 | 0.9% | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 475,000 | $2,182 萬 | 0.7% | – |
| ALECAlector, Inc. | COM | 4,631,998 | $2,159 萬 | 0.7% | 歷史 |
| FATEFate Therapeutics Inc | COM | 5,572,607 | $1,950 萬 | 0.6% | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,000,000 | $1,818 萬 | 0.6% | 歷史 |
| EDITEditas Medicine, Inc. | COM | 4,900,334 | $1,671 萬 | 0.5% | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 4,184,100 | $1,536 萬 | 0.5% | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 531,857 | $744.1 萬 | 0.2% | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,553,996 | $528.4 萬 | 0.2% | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 219,648 | $251.3 萬 | 0.1% | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 140,000 | $234.2 萬 | 0.1% | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 674,833 | $218.6 萬 | 0.1% | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $178.1 萬 | 0.1% | 歷史 |
| MGXMetagenomi Therapeutics, Inc. | COM | 307,500 | $66.7 萬 | <0.1% | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 48,100 | $38.5 萬 | <0.1% | 歷史 |